$18.68
2.45% yesterday
NYSE, Nov 15, 10:10 pm CET
ISIN
US05350V1061
Symbol
AVNS

Avanos Medical, Inc. Target price 2024 - Analyst rating & recommendation

Avanos Medical, Inc. Classifications & Recommendation:

Buy
33%
Hold
67%

Avanos Medical, Inc. Price Target

Target Price $22.50
Price $18.68
Potential
Number of Estimates 2
2 Analysts have issued a price target Avanos Medical, Inc. 2025 . The average Avanos Medical, Inc. target price is $22.50. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 3 analysts: 1 Analysts recommend Avanos Medical, Inc. to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Avanos Medical, Inc. stock has an average upside potential 2025 of . Most analysts recommend the Avanos Medical, Inc. stock at Hold.

Sales and Margin forecast 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 673.30 685.43
17.89% 1.80%
EBITDA Margin 16.11% 16.19%
1.88% 0.47%
Net Margin -9.08% 0.60%
251.38% 106.61%

3 Analysts have issued a sales forecast Avanos Medical, Inc. 2024 . The average Avanos Medical, Inc. sales estimate is

$685m
Unlock
. This is
0.58% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$686m 0.65%
Unlock
, the lowest is
$685m 0.51%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $673m 17.89%
2024
$685m 1.80%
Unlock
2025
$713m 4.04%
Unlock
2026
$756m 5.94%
Unlock
2027
$791m 4.73%
Unlock

1 Analyst has issued an EBITDA forecast Avanos Medical, Inc. 2024 . The average Avanos Medical, Inc. EBITDA estimate is

$111m
Unlock
. This is
2.49% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$111m 2.49%
Unlock
, the lowest is
$111m 2.49%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $109m 16.35%
2024
$111m 2.30%
Unlock
2025
$131m 18.02%
Unlock

EBITDA Margin

2023 16.11% 1.88%
2024
16.19% 0.47%
Unlock
2025
18.37% 13.47%
Unlock

The average Avanos Medical, Inc. net profit estimate is

$4.1m
Unlock
. This is
73.50% lower
Unlock
than the net profit for the last 12 months(TTM).

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-61.1m 224.30%
2024
$4.1m 106.77%
Unlock
2025
$18.4m 343.96%
Unlock

Net Margin

2023 -9.08% 251.38%
2024
0.60% 106.61%
Unlock
2025
2.58% 330.00%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share $ -1.33 0.09
224.30% 106.77%
P/E 207.56
EV/Sales 1.42

The average Avanos Medical, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$0.09
Unlock
. This is
73.53% lower
Unlock
than earnings per share in the financial year 2023.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-1.33 224.30%
2024
$0.09 106.77%
Unlock
2025
$0.40 344.44%
Unlock

P/E ratio

Current 55.38 419.56%
2024
207.56 274.79%
Unlock
2025
46.70 77.50%
Unlock

Based on analysts' sales estimates for 2024, the Avanos Medical, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.43 7.14%
2024
1.42 0.87%
Unlock
2025
1.36 3.88%
Unlock
2026
1.29 5.61%
Unlock
2027
1.23 4.51%
Unlock

P/S ratio

Current 1.26 0.94%
2024
1.25 0.57%
Unlock
2025
1.20 3.89%
Unlock
2026
1.14 5.61%
Unlock
2027
1.09 4.51%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today